We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Fluid Lavage of Open Wounds (FLOW)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00788398
Recruitment Status : Completed
First Posted : November 10, 2008
Last Update Posted : February 11, 2016
Sponsor:
Collaborators:
McMaster University
United States Department of Defense
Information provided by (Responsible Party):
Prisma Health-Upstate

Brief Summary:
Open fracture wounds are a constant challenge to orthopaedic surgeons, with infections a common complication. There is currently little evidence as to which is the most effective way to wash out these wounds. This study is a multi-center, prospective, randomized study. The infection rates will be compared between irrigation using high pressure versus low pressure versus gravity flow, and also saline versus a soap solution as the irrigation solution. The results from this study will help to determine the best method of washing out open fractures wounds. In this study, all open wounds will be washed out using methods commonly used by orthopaedic surgeons

Condition or disease Intervention/treatment Phase
Open Fracture Wounds Procedure: Saline Solution Procedure: Soap solution Procedure: Gravity Flow Irrigation Procedure: Low Pressure Irrigation Procedure: High Pressure Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 2540 participants
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Double (Participant, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Fluid Lavage of Open Wounds (FLOW): A Multi-center, Blinded, Factorial Trial Comparing Alternative Irrigating Solutions and Pressures in Patients With Open Fractures
Study Start Date : June 2009
Actual Primary Completion Date : January 2015
Actual Study Completion Date : April 2015

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Active Comparator: Saline, gravity flow Procedure: Saline Solution
Irrigation with Saline

Procedure: Gravity Flow Irrigation
Gravity flow irrigation will be standardized across participating centers as 3L bags of normal saline (alone or with soap solution) suspended 6-8 feet above floor level using an I.V. pole. Irrigation tubing (measuring 1/4 - 3/8 inch inner diameter) will be connected to the 3L bag and secured with a stopcock (or compressive device) until ready for use.

Active Comparator: Saline, Low Pressure Procedure: Saline Solution
Irrigation with Saline

Procedure: Low Pressure Irrigation

Irrigation with the Stryker SurgiLav System. At the low pressure setting delivers 5.9 p.s.i. pressure. The high-flow irrigator tip will be held perpendicular to and 5cm above the wound.

Irrigation with the Zimmer PulsaVac. For low pressure delivery, the shower tip will be used at the low pressure setting which delivers a pressure of 5.8 p.s.i.


Active Comparator: Saline, High Pressure Procedure: Saline Solution
Irrigation with Saline

Procedure: High Pressure

Irrigation with the Stryker SurgiLav System. For the high pressure delivery, the multi-orifice tip will be used at the high setting which delivers a pressure of 30 p.s.i.

Irrigation with the Zimmer PulsaVac System: For the high pressure delivery the shower tip will be used at the high pressure setting which delivers a pressure of 23 p.s.i.


Active Comparator: Soap, Gravity Flow Procedure: Soap solution
Irrigation with Castile Soap Solution (80 ml per 3L bag of saline)

Procedure: Gravity Flow Irrigation
Gravity flow irrigation will be standardized across participating centers as 3L bags of normal saline (alone or with soap solution) suspended 6-8 feet above floor level using an I.V. pole. Irrigation tubing (measuring 1/4 - 3/8 inch inner diameter) will be connected to the 3L bag and secured with a stopcock (or compressive device) until ready for use.

Active Comparator: Soap, low pressure Procedure: Soap solution
Irrigation with Castile Soap Solution (80 ml per 3L bag of saline)

Procedure: Low Pressure Irrigation

Irrigation with the Stryker SurgiLav System. At the low pressure setting delivers 5.9 p.s.i. pressure. The high-flow irrigator tip will be held perpendicular to and 5cm above the wound.

Irrigation with the Zimmer PulsaVac. For low pressure delivery, the shower tip will be used at the low pressure setting which delivers a pressure of 5.8 p.s.i.


Active Comparator: Soap, high pressure Procedure: Soap solution
Irrigation with Castile Soap Solution (80 ml per 3L bag of saline)

Procedure: High Pressure

Irrigation with the Stryker SurgiLav System. For the high pressure delivery, the multi-orifice tip will be used at the high setting which delivers a pressure of 30 p.s.i.

Irrigation with the Zimmer PulsaVac System: For the high pressure delivery the shower tip will be used at the high pressure setting which delivers a pressure of 23 p.s.i.





Primary Outcome Measures :
  1. Re-operation within 12 months post initial surgery to treat an infection, manage a wound healing problem, or promote fracture healing. [ Time Frame: within 12 months ]

Secondary Outcome Measures :
  1. Patient function and quality of life measured by the Short Form-12 (SF-12) and the EuroQol-5D [ Time Frame: 12 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   14 Years to 85 Years   (Child, Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Men or women who are skeletally mature.
  2. Fracture of any extremity with complete radiographs.
  3. Open fractures (Gustilo-Anderson Types I-IIIB) (Table 2)*.
  4. Fracture requiring operative fixation.
  5. Provision of informed consent.

Exclusion Criteria:

  1. Open fractures with an associated vascular deficit (Gustilo-Anderson Type IIIC).
  2. Known allergy to detergents or castile soap ingredients.
  3. Previous wound infection or history of osteomyelitis in the injured extremity.
  4. Previous fracture with retained hardware in injured extremity that will interfere with new implant fixation.
  5. Surgical delay to operative wound management greater than 24 hours from hospital admission.
  6. Use of immunosuppressive medication within 6 months.
  7. Immunological deficient disease conditions (e.g. HIV).
  8. Fracture of the hand (metacarpals and phalanges).
  9. Fracture of the toes (phalanges).
  10. Likely problems, in the judgment of the investigators, with maintaining follow-up. We will, for example, exclude patients with no fixed address, those who report a plan to move out of town in the next year, or intellectually challenged patients without adequate family support.
  11. Previous randomization in this study or a competing study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00788398


Locations
Show Show 31 study locations
Sponsors and Collaborators
Prisma Health-Upstate
McMaster University
United States Department of Defense
Investigators
Layout table for investigator information
Principal Investigator: Kyle J. Jeray, MD Greenville Hospital System
Principal Investigator: Bradley Petrisor, MD Hamilton Health Sciences Corporation
Principal Investigator: Mohit Bhandari, MD McMaster University
Principal Investigator: Gordan Guyatt, M.D. McMaster University
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Prisma Health-Upstate
ClinicalTrials.gov Identifier: NCT00788398    
Other Study ID Numbers: GHS-03-08-06
W81XWH-08-1-0473
First Posted: November 10, 2008    Key Record Dates
Last Update Posted: February 11, 2016
Last Verified: February 2016
Additional relevant MeSH terms:
Layout table for MeSH terms
Wounds and Injuries
Fractures, Open
Fractures, Bone
Pharmaceutical Solutions